Prasterone

普拉睾酮

Report date: 2026/04/22 20:01:10
NME

Base Information

Drug NamePrasterone
Drug Alias Name去氢异雄甾酮Prasteronum脱氢表雄酮Prasterona去氢表雌酮 +[19] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonistsEstrogen receptors agonists
TargetsAndrogen ReceptorEstrogen receptors
Therapy Area/IndicationsVasomotor symptomVulvar and vaginal atrophyMenopausal symptoms +[40] 
Global Approved IndicationsVulvar and vaginal atrophyAtrophyDyspareunia
Approved Indications in ChinaVulvar and vaginal atrophy
Original Approved Country/TerritoryUnited States
Original Approved Date2016/11/16
Country/TerritoryCanadaUnited StatesMexico +[11] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesEndoceutics
China Registration ClassN/A

Develop Information

Active CompaniesLee'S Pharmaceutical LtdCosette Pharmaceuticals IncMillicent Pharma Ltd +[11] 
Inactive CompaniesEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentNational Center For Complementary And Integrative HealthCairo University +[26] 
Active IndicationsVulvar and vaginal atrophyAtrophyVaginal Diseases +[12] 
Inactive IndicationsVasomotor symptomMenopausal symptomsSexual Dysfunctions, Psychological +[28] 

Other Information

ATC CodeA14AA07G03XX01
Related LinksWikipediaDrugBankKEGG